Google Life Sciences, a research division under Alphabet, began as a life sciences team under Google[X], the company’s experimental lab. Now branded as Verily, the company will continue to investigate and research how to develop and leverage technology to improve human health.
“Verily is a new company that is focused on bringing together technology, science and medicine in the places where we think we can have the biggest impact on the detection, management and prevention of disease,” a Verily spokeswoman told The Wall Street Journal.
Some of Verily‘s projects (initiated when it was still operating as Google Life Sciences) include a smart contact lens and the Baseline Study, a multiyear initiative aiming to identify the traits of healthy humans.
More articles on health IT:
The upside of EHRs: 3 physicians’ perspectives on what they get right
Theranos CEO says business is better than ever, as emails suggest DOD scrutiny since 2012
3 of the biggest health IT rivalries: The cloud, EHRs & wearables
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.